NCT00970099已完成1 期
Mechanism of Exercise Training in Lean Insulin-Resistant Non-Diabetics
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 149
- 试验地点
- 2
- 主要终点
- insulin sensitivity and insulin signaling
研究概览
简要总结
The study is designed to test the following primary hypothesis:
- Aerobic exercise training will improve insulin sensitivity in insulin resistant subjects through changes in the major cellular signaling pathways and and/or their regulators.
Accordingly, the proposed study is designed to accomplish the following specific aims:
- Quantitate how exercise training improves insulin sensitivity and decreases cardiovascular risk factors in a general population of lean, nondiabetic, insulin resistant subjects. Effects on known cardiovascular risk factors including blood pressure and serum lipoproteins will be evaluated. Change in regional adiposity will also be measured
- Determine the effects of a program of regular aerobic exercise on in the insulin receptor signaling pathway. Biopsies of vastus lateralis muscle from insulin resistant subjects will be obtained before and after a hyperinsulinemic glucose clamp. This procedure will take place in the untrained state and after exercise training. The investigators will measure changes in the insulin receptor and the activity of the major components of the intracellular insulin signaling pathway. The investigators will also look intracellular proteins that regulate this signaling pathway.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 50 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Men and women aged 20-50
- •No regular exercise for past 2 years
排除标准
- •Diabetes, Cardiovascular disease, Pregnant or lactating females,BMI >27
- •Medications that may interfere with carbohydrate metabolism - glucocorticoids, adrenergic agonists, ACE inhibitors, alpha blockers, diuretics, beta blockers, oral contraceptives, HMG CoA reductase inhibitors
- •History of epilepsy, cancer, hepatitis, active infection, active Graves' disease, cystic fibrosis, sickle cell anemia, peripheral vascular disease, cerebrovascular disease, asthma
- •Any medical condition that in the opinion of the investigator will interfere with safe completion of the trial
- •Inability to give informed consent
- •Prior participation in a clinical trial that could potentially alter insulin sensitivity: e.g., use of new insulin sensitizers
- •HIV seropositive
- •Anemia (Hgb < 12 g/dl)
结局指标
主要结局
insulin sensitivity and insulin signaling
时间窗: 12 weeks
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Aerobic Plus Resistance Training and Insulin Sensitivity in African American MenType 2 DiabetesInsulin ResistanceNCT01787617Pennington Biomedical Research Center113
已完成
3 期
Exercise Training, Insulin Resistance and Coronary Artery DiseaseGlucose IntoleranceCoronary Artery DiseaseNCT00412815London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's60
已完成
不适用
Influence of Exercise Therapy on Insulin Resistance in Patients With Heart FailureChronic Heart FailureNCT02000479Hasselt University29
暂停
不适用
Mechanisms of Insulin Resistance and Exercise in South AsiansInsulin ResistanceNCT04007926University of Glasgow66
已完成
不适用
Molecular Mechanisms of Exercise Benefits to Insulin Resistant PeopleInsulin ResistanceObesityNCT04158375Mayo Clinic58
